The FDA announced on March 22, 2019, that InvaGen Pharmaceuticals, Inc. voluntarily recalled Testosterone Cypionate Injection due to the presence of particulate matter. The agency classified the recall as Class II.
How to tell if you have it
- Brand: InvaGen Pharmaceuticals
- Product: Testosterone Cypionate Injection, USP, 1000 mg/10 mL (100 mg/mL), For intramuscular use only, 10 mL Vial, Multiple-Dose, Rx Only
- NDC: 69097-536-37
- Lots: GH80216 Exp 1/2020; GH80322, GH80323 Exp 2/2020; GH90072 Exp 12/2020
- Quantity: 75,968 vials
The hazard
The recall addresses the presence of particulate matter in the injection. The FDA classified the action as a Class II recall.
Context
GovInfoNow's records show InvaGen Pharmaceuticals, Inc. has 7 other recalls on record since March 5, 2018. Other recent recalls of similar products include Asteria Health Testosterone Pellets Recall (Jan. 26, 2026), B. Braun Medical Lactated Ringer's Injection Recall (April 28, 2026), and Sunny Pharmtech Cyclophosphamide Injection Recall (July 17, 2026).